Drugs / Enecavir
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01799486 | Feb 2013 | cirrhosis of liver | Lin Bingliang | Unknown | No outcome recorded |
| Phase 4 | NCT01693679 | Sep 2012 → Apr 2014 | cirrhosis of liver | Shao-quan Zhang | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Enecavir | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01693679 ↗ |
| Route | Oral | “Enecavir,0.5mg,daily,oral” NCT01693679 ↗ |